Literature DB >> 35382427

A cross-sectional study of COVID-19 outbreak in Indian population.

Murugesan Arumugam1, Raleena Begum Haja Najimudeen1, Arya Vijayan1, Bhuvaneshwari Sathyamoorthy1, Prashant S Patole1.   

Abstract

Background: Presently India is the second most populous country in the world with an estimated population of 1.4 billion people and has recently been affected by COVID-19 pandemic and subsequent mutant viral outbreak. To date, India has administered its population with over 1.30 billion cumulative doses of COVID-19 vaccine. The consequences of COVID-19 vaccination on the outbreak in India has not been reported until now. Therefore, we probed to assess the impact of COVID-19 outbreak in India from December 2019 to December 2021.
Methods: Indian COVID-19 related data were extracted from "ourworldindata.org" and "cowin.gov.in" databases. The incidence rate of COVID-19 per million people was calculated and other parameters such as new cases, positive rate, reproduction rate, new death and stringency index values were extracted from the database for statistical analysis.
Results: Data indicate that the COVID-19 positive rate declined as the number of vaccinations rose over time. The Pearson correlation values between new cases and the cumulative percentage of vaccination or the percentage of fully vaccinated population showed no correlation (P < 0.01). COVID-19 vaccination has significantly decreased the R-value and positive rate of SARS-CoV-2 in India (P < 0.01). Furthermore, containment measures showed no correlation with the incidence rate of SARS-CoV-2 in India which may be in contradictory to the global trends.
Conclusion: Vaccination against COVID-19 was efficacious in the control of the SARS-CoV-2 outbreak and the decrease in the positive rate. Further, the containment measures had no effect on the spread of COVID-19 infection in India, thus far.
© 2022 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.

Entities:  

Keywords:  COVID-19; Impact of vaccination; India; Outbreak; Vaccination

Year:  2022        PMID: 35382427      PMCID: PMC8972981          DOI: 10.1016/j.amsu.2022.103554

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


  26 in total

1.  The COVID-19 vaccine development landscape.

Authors:  Tung Thanh Le; Zacharias Andreadakis; Arun Kumar; Raúl Gómez Román; Stig Tollefsen; Melanie Saville; Stephen Mayhew
Journal:  Nat Rev Drug Discov       Date:  2020-05       Impact factor: 84.694

Review 2.  Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.

Authors:  W Joost Wiersinga; Andrew Rhodes; Allen C Cheng; Sharon J Peacock; Hallie C Prescott
Journal:  JAMA       Date:  2020-08-25       Impact factor: 56.272

Review 3.  Review of COVID-19 Vaccines Approved in the United States of America for Emergency Use.

Authors:  Deepa Vasireddy; Paavani Atluri; Srikrishna Varun Malayala; Rachana Vanaparthy; Gisha Mohan
Journal:  J Clin Med Res       Date:  2021-04-27

4.  Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Authors:  Merryn Voysey; Sue Ann Costa Clemens; Shabir A Madhi; Lily Y Weckx; Pedro M Folegatti; Parvinder K Aley; Brian Angus; Vicky L Baillie; Shaun L Barnabas; Qasim E Bhorat; Sagida Bibi; Carmen Briner; Paola Cicconi; Andrea M Collins; Rachel Colin-Jones; Clare L Cutland; Thomas C Darton; Keertan Dheda; Christopher J A Duncan; Katherine R W Emary; Katie J Ewer; Lee Fairlie; Saul N Faust; Shuo Feng; Daniela M Ferreira; Adam Finn; Anna L Goodman; Catherine M Green; Christopher A Green; Paul T Heath; Catherine Hill; Helen Hill; Ian Hirsch; Susanne H C Hodgson; Alane Izu; Susan Jackson; Daniel Jenkin; Carina C D Joe; Simon Kerridge; Anthonet Koen; Gaurav Kwatra; Rajeka Lazarus; Alison M Lawrie; Alice Lelliott; Vincenzo Libri; Patrick J Lillie; Raburn Mallory; Ana V A Mendes; Eveline P Milan; Angela M Minassian; Alastair McGregor; Hazel Morrison; Yama F Mujadidi; Anusha Nana; Peter J O'Reilly; Sherman D Padayachee; Ana Pittella; Emma Plested; Katrina M Pollock; Maheshi N Ramasamy; Sarah Rhead; Alexandre V Schwarzbold; Nisha Singh; Andrew Smith; Rinn Song; Matthew D Snape; Eduardo Sprinz; Rebecca K Sutherland; Richard Tarrant; Emma C Thomson; M Estée Török; Mark Toshner; David P J Turner; Johan Vekemans; Tonya L Villafana; Marion E E Watson; Christopher J Williams; Alexander D Douglas; Adrian V S Hill; Teresa Lambe; Sarah C Gilbert; Andrew J Pollard
Journal:  Lancet       Date:  2020-12-08       Impact factor: 79.321

5.  Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes.

Authors:  Judith van Paassen; Jeroen S Vos; Eva M Hoekstra; Katinka M I Neumann; Pauline C Boot; Sesmu M Arbous
Journal:  Crit Care       Date:  2020-12-14       Impact factor: 9.097

Review 6.  Mutations in SARS-CoV-2; Consequences in structure, function, and pathogenicity of the virus.

Authors:  Behnaz Bakhshandeh; Zohreh Jahanafrooz; Ardeshir Abbasi; Matin Babaee Goli; Mahya Sadeghi; Mohammad Sadeq Mottaqi; Maryam Zamani
Journal:  Microb Pathog       Date:  2021-03-13       Impact factor: 3.848

7.  Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.

Authors:  Awadhesh Kumar Singh; Akriti Singh; Altamash Shaikh; Ritu Singh; Anoop Misra
Journal:  Diabetes Metab Syndr       Date:  2020-03-26

8.  WHO Declares COVID-19 a Pandemic.

Authors:  Domenico Cucinotta; Maurizio Vanelli
Journal:  Acta Biomed       Date:  2020-03-19
View more
  1 in total

1.  Impact of Vaccine and Immunity Passports in the Context of COVID-19: A Time Series Analysis in Overseas France.

Authors:  Samuel d'Almeida
Journal:  Vaccines (Basel)       Date:  2022-05-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.